unknown
Stage
About
Diadem Biotherapeutics develops engineered extracellular vesicles to activate or repress immune cell receptors, aiming to treat cancer and autoimmune diseases using their DECOSTAR™ platform.
Explore Diadem Biotherapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.